共 94 条
[1]
Steinkuller PG(1999)Childhood blindness J Am Assoc Pediatr Ophthalmol Strabismus 3 26-32
[2]
Du L(2013)Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iran Iran Red Crescent Med J 15 229-9
[3]
Gilbert C(2005)The international classification of retinopathy of prematurity revisited Arch Ophthalmol 123 991-277
[4]
Foster A(2019)The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China Int J Ophthalmol 12 1146-70 e1
[5]
Collins ML(2003)Retinopathy of prematurity: molecular pathology and therapeutic strategies Am J Pharmacogenomics 3 261-1603
[6]
Coats DK(2008)Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity Ophthalmology 115 1065-838
[7]
Abrishami M(2009)Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity Ophthalmology 116 1599-183
[8]
Maemori G-A(2008)Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II Retina 28 831-33 e1
[9]
Boskabadi H(2011)Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan Ophthalmology 118 176-1608
[10]
Yaeghobi Z(2012)Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity Am J Ophthalmol 153 327-129